1,086 material Form 8-K filings that 883 companies we cover made with the SEC in July 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Asbury Automotive Group completed its acquisition of substantially all assets of The Herb Chambers Companies on July 21, 2025, for an aggregate net purchase price of approximately $1.45 billion. The deal adds 33 dealerships and 52 franchises in Massachusetts and Rhode Island, marking Asbury's entry into the Northeastern U.S. The purchase was funded with $750 million of added credit facility capacity, $546.5 million of real estate mortgage borrowings, and cash on hand, which adds significant debt for shareholders to consider.
Aggregate net purchase price of approximately $1.45 billion, including $750 million for goodwill and approximately $610 million for real estate and leasehold improvements
Senior Credit Facility expanded by $750 million; Real Estate Facility borrowings totaled $546,528,750 with a ten-year maturity
Acquired businesses had $3.2 billion in revenue in 2024 across 33 dealerships, 52 franchises and three collision centers
Financial statements and pro forma information will be filed by amendment within 71 calendar days
Par Pacific signed a definitive agreement to form ProjectCo, a joint venture for a renewable fuels facility co-located with its Kapolei Refinery in Hawaii. Alohi, owned by Mitsubishi and ENEOS, will hold a 36.5% stake for $100 million in cash, while Par Pacific keeps the remaining interest and runs the project; closing is expected in the second half of 2025.
Alohi Renewable Energy, owned by Mitsubishi and ENEOS, will hold 36.5% of ProjectCo for $100 million in cash
Par Pacific will commit cash contributions of up to $21,039,382, less qualifying construction costs from July 1, 2025 to closing
Facility is expected to be completed and operational by the end of 2025, producing about 61 million gallons per year
Transaction is expected to close in the second half of 2025, subject to customary conditions and regulatory approvals
AIG said John Neal, former CEO of Lloyd's of London, will join as President effective December 1, 2025, reporting to Chairman and CEO Peter Zaffino and leading the General Insurance organization. The filing sets his pay package, including a $1.25 million base salary and a $3.75 million target annual cash bonus, which gives shareholders a clear view of the cost of the appointment.
Start date: December 1, 2025; Neal reports to Chairman and CEO Peter Zaffino
Base salary of $1,250,000; target annual cash bonus of $3,750,000 with a guarantee of no less than target for 2025
Target annual equity award of $5,000,000; on start date, RSUs with initial grant value of $4,500,000 vesting over three years and a $2,700,000 cash payment
West Pharmaceutical Services appointed Robert McMahon, formerly CFO of Agilent Technologies, as Senior Vice President and Chief Financial Officer effective August 4, 2025, succeeding Bernard Birkett, who is retiring and will serve as Senior Advisor to the CEO through December 31, 2025. The filing discloses pay terms including an $800,000 base salary, a $3,115,000 sign-on bonus and a $4,200,000 replacement equity grant, which matter to shareholders as a change in the company's top finance role and a related compensation cost.
Robert McMahon becomes SVP and CFO effective August 4, 2025, overseeing finance, audit, treasury, tax, investor relations and procurement.
Offer terms include an $800,000 initial base salary and an annual bonus target of 80% of base salary.
One-time cash sign-on bonus of $3,115,000 and a replacement equity grant with a grant date fair value of $4,200,000.
LTI award with grant date fair value of $3,000,000 is scheduled for August 11, 2025.
Alexandria Real Estate Equities reported a second-quarter 2025 net loss attributable to common stockholders of $109.6 million, or $(0.64) per diluted share, compared with net income of $42.9 million, or $0.25 per share, a year earlier. The company lowered its 2025 projected earnings per share to $0.40 to $0.60 from $1.36 to $1.56 as of April 28, 2025, which reduces expected earnings for shareholders.
2Q25 net loss attributable to common stockholders of $109.6 million, or $(0.64) per diluted share, versus net income of $42.9 million, or $0.25 per share, in 2Q24
2Q25 total revenues of $762.0 million, down from $766.7 million in 2Q24
2Q25 FFO per diluted share, as adjusted, of $2.33, compared with $2.36 in 2Q24
2025 projected EPS lowered to $0.40 to $0.60 from $1.36 to $1.56 as of April 28, 2025; 2Q25 included a $129.6 million impairment of real estate
Crown Holdings reported second-quarter 2025 results on July 21, 2025, with adjusted diluted earnings per share up 19% to $2.15 and net sales of $3,149 million. The company raised its full-year 2025 adjusted diluted EPS guidance to $7.10 to $7.50, which signals stronger expected earnings for shareholders.
Q2 2025 adjusted diluted EPS rose 19% to $2.15 from $1.81; reported diluted EPS was $1.56 versus $1.45
Net sales were $3,149 million versus $3,040 million; income from operations was $391 million versus $379 million
Full-year 2025 adjusted diluted EPS guidance raised to $7.10 to $7.50; third-quarter adjusted EPS expected at $1.95 to $2.05
Adjusted free cash flow expected at approximately $900 million for 2025
Motorola Solutions entered two delayed-draw term loan agreements on July 21, 2025, each with $750.0 million in lending commitments, to help finance its acquisition of Silvus Technologies. The loans fund only at the closing of the Silvus acquisition, so they add borrowing capacity tied to that deal rather than drawing debt now.
364-day loan with Mizuho Bank as administrative agent: $750.0 million commitments; the company can extend part of the loan to a second anniversary of funding, with a 5 basis point extension fee.
Three-year loan with Bank of America, N.A. as administrative agent: $750.0 million commitments, maturing three years from funding.
Both loans are senior and unsecured, bear interest based on Term SOFR or a base rate plus an margin tied to the company's credit rating, and include a leverage ratio covenant.
Commitments terminate no later than May 26, 2026, or five business days after the Silvus outside date, if the deal does not close or the purchase agreement is terminated.
Agilysys reported record fiscal 2026 first-quarter revenue of $76.7 million, up 20.7% from a year earlier, with subscription revenue up 44.3%. The company raised its full-year subscription revenue growth guidance to 27% from 25%, while keeping total revenue guidance at $308 million to $312 million, but GAAP net income fell to $4.9 million from $14.1 million.
Total net revenue rose to $76.7 million from $63.5 million in the year-earlier quarter.
GAAP net income was $4.9 million, or $0.17 per diluted share, versus $14.1 million, or $0.50 per diluted share, a year earlier.
Adjusted diluted EPS (non-GAAP) was $0.33 versus $0.30; free cash flow (non-GAAP) was negative $5.0 million versus $0.2 million.
Full-year fiscal 2026 subscription revenue growth guidance was raised to 27% from 25%; total revenue guidance of $308 million to $312 million was unchanged.
Dentsply Sirona said its board appointed Daniel Scavilla, a director since February 2025 and former Globus Medical CEO, as president and chief executive officer effective August 1, 2025, succeeding Simon Campion, who leaves on July 31, 2025. The company also issued preliminary second quarter 2025 results and reaffirmed its 2025 outlook, which gives shareholders a clearer view of the leadership transition and near-term results, though the filing gives no prior-year comparison.
Preliminary second quarter 2025 net sales are expected to be approximately $935 million, with adjusted EPS between $0.50 and $0.52.
The company reaffirmed its 2025 outlook from its May 8, 2025 earnings release and plans to report second quarter results on August 7, 2025.
Scavilla will receive an annual base salary of $1,030,000 and a target bonus of 135% of base salary; Campion resigned from the board effective July 20, 2025, reducing its size from eleven to ten members.
Sensata Technologies named Andrew Lynch as its Executive Vice President and Chief Financial Officer, effective immediately on July 21, 2025. Lynch had served as interim CFO since May 16, 2025, and has been with the company since 2009. The appointment makes permanent the leadership of all global financial activities, and his pay package is set out in the filing.
Lynch's base salary is $540,000 per year, with an annual cash bonus target of 100% of salary.
He receives a $600,000 equity grant, split 45% restricted stock units and 55% performance-based restricted stock units.
Lynch served as interim CFO from May 16, 2025, and previously led investor relations from 2024.
The full employment agreement will be filed with the Form 10-Q for the period ending June 30, 2025.
Daniel Scavilla resigned as Globus Medical's President, CEO and director effective July 18, 2025, to pursue another opportunity. The board named Keith Pfeil, the company's COO and CFO, as President and CEO and a director, and Kyle Kline as CFO, effective the same day. The company also reported preliminary second-quarter 2025 sales of approximately $745.3 million, up 18.4% as reported, and reaffirmed its full-year 2025 guidance.
Daniel Scavilla resigned as President, CEO and director effective July 18, 2025; the filing says the resignation was not due to any disagreement with the company.
Keith Pfeil was appointed President and CEO effective July 18, 2025, with his base salary rising to $490,000, prorated for 2025.
Preliminary Q2 2025 sales were approximately $745.3 million, up 18.4% as reported; base business sales were approximately $650.8 million, up 3.3%.
The company reaffirmed full-year 2025 revenue guidance of $2.80 billion to $2.90 billion and non-GAAP diluted EPS guidance of $3.00 to $3.30.
Bruker Corporation said preliminary second quarter 2025 revenue was $795-$798 million, roughly flat year-over-year, while non-GAAP organic revenue fell about 7%. Non-GAAP EPS is expected at $0.32-$0.34, a decline of about $0.19 per share that includes a $0.06 foreign currency headwind. The figures are unaudited and subject to quarter-end closing, and the company will report final results on August 4, 2025.
Preliminary Q2 2025 revenue of $795-$798 million, approximately flat reported year-over-year
Non-GAAP organic revenue declined about 7%; constant-exchange rate revenue declined about 3%
Non-GAAP EPS expected at $0.32-$0.34, about $0.19 per share lower year-over-year, including a $0.06 foreign currency headwind
Final results and earnings call scheduled for August 4, 2025, with the call at 8:30 a.m. EDT
Roper Technologies reported second quarter 2025 revenue up 13% to $1.94 billion, GAAP net earnings up 12% to $378 million, and adjusted DEPS up 9% to $4.87. The company raised its full-year 2025 adjusted DEPS guidance low end to $19.90 from $19.80 and lifted its total revenue growth outlook to about 13% from about 12%, while also announcing an $800 million acquisition of Subsplash expected to close later this month.
Q2 2025 revenue of $1.94 billion rose 13%, with organic growth of 7% and acquisitions adding 6%.
GAAP net earnings were $378 million, up 12%; adjusted DEPS was $4.87, up 9%.
Full-year 2025 adjusted DEPS guidance is $19.90 to $20.05, versus prior $19.80 to $20.05; total revenue growth outlook is about 13%, versus about 12% previously.
Roper signed a definitive agreement to acquire Subsplash for $800 million, with closing expected later in July 2025.
Cleveland-Cliffs reported second-quarter 2025 revenue of $4.9 billion, up from $4.6 billion in the first quarter, but posted a GAAP net loss of $470 million that included $323 million of non-recurring charges tied to idled facilities. Adjusted EBITDA swung to $97 million from a loss of $174 million in the first quarter, and the company updated several full-year 2025 expectations.
Revenue of $4.9 billion for Q2 2025, compared with $4.6 billion in Q1 2025 and $5.1 billion in Q2 2024.
GAAP net loss of $470 million; adjusted net loss of $247 million, or $0.50 per diluted share.
Adjusted EBITDA of $97 million, versus a $174 million loss in Q1 2025.
Full-year 2025 outlook: capital expenditures cut to about $600 million from $625 million; depreciation, depletion and amortization raised to about $1.2 billion from about $1.1 billion.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.